• Biopharma PEG Elevates ADC Development with Monodispersed PEGs in Versatile Scales

    Nov 13, 2023, 08:55 by
    Biopharma PEG introduces monodispersed PEGs, including mPEG36-NH2,NH2-PEG24-COOH, OH-PEG9-OH, mPEG8-SPA , for ADC development at diverse scales. R&D Director highlights their role in modulating ADC properties.
    Full story
  • uMotif and Cogstate Power CNS Research, Combining Patient-Centric eCOA/ePRO Data Capture Platform with Market-Leading Cognitive Solutions

    Nov 10, 2023, 06:58 by
    Companies building on existing studies in areas including psychedelics to better support CNS research with innovations to quantifiably increase data quality, improve study timelines, and enhance the clinical trial site and patient experience
    Full story
  • EU Clinical Trial Regulation 536/2014: Real-World Learnings, Best Practices For Successful Document Submissions In An Evolving System

    Nov 10, 2023, 01:00 by User Not Found
    Clinical Research News | The European Union Clinical Trial Regulation 536/2014 went live on January 31, 2022, with the purpose of harmonizing clinical trial document submission processes within the European Union member states and improving transparency to the public.
    Full story
  • Seeing the Bigger Picture for AI Application With Michael Ibara

    Nov 8, 2023, 01:00 by User Not Found
    Clinical Research News | Though increasing in popularity, the application of AI is not as widespread as some may think. In the case of clinical trials, AI is seldom used to help with organizing data, managing studies, and processing information.
    Full story
  • Groundbreaking treatment for Alcohol Use Disorder shown to halve alcohol consumption amongst heavy drinkers in three months at phase II: a new hope for patients

    Nov 7, 2023, 06:53 by
    • The trial showed that KT-110 has superior efficacy in reducing alcohol consumption • KT-110 will be deliverable in a once-daily tablet (proprietary formulation) • KT-110’s mode of action is novel to Alcohol Use Disorder (AUD) and works by simultaneously modulating the noradrenergic and serotonergic brain receptors that counteract the neurobiological processes involved in addiction • Alcohol dependence, or AUD, is a serious public health issue and the medical need for the treatment of alcoholism is considerable and unmet • Kinnov Therapeutics expects to have clear guidance from the FDA in early 2024 on the phase III trial
    Full story
  • Inizio Medical Calls for Urgent Action to Adopt AI in All Aspects of Healthcare Communication

    Nov 7, 2023, 06:53 by
    One of the world’s leading communication companies Inizio Medical has issued an urgent call to action for businesses to adopt AI in all aspects of healthcare communication or risk being left behind by their competitors.
    Full story
  • Innovation Opportunities in Vendor Selection and Partnerships

    Nov 7, 2023, 01:00 by User Not Found
    Clinical Research News | In clinical research, outsourcing is more of a partnership than it is just handing off work to other teams. The stakes are high, and the success of outsourcing relationships directly impact the success or failure of a pharmaceutical program.
    Full story
  • Simbec-Orion and biotx.ai launch strategic partnership to de-risk early-stage drug development with AI supported clinical trial design

    Nov 6, 2023, 08:30 by
    Simbec-Orion, a full-service mid-size CRO, and biotx.ai, a developer of AI-enabled causal modelling for drug development, have announced their strategic partnership to bring AI-powered insights and predictive models to support data-driven clinical trial design.
    Full story
  • Decentralized Clinical Trials: Navigating The Regulatory Landscape For Efficient And Patient-Centric Research

    Nov 3, 2023, 01:00 by User Not Found
    Clinical Research News | The global decentralized clinical trials (DCTs) market is expected to see significant growth in the coming years. In 2021, the market was valued at $8.8 billion. And in 2026, the market is projected to reach $14.2 billion. Several key factors are fueling this transformation, including the impact of COVID-19 lockdowns and restrictions, the increasing demand for faster and more cost-effective drug trials, the growing preference of patients to participate in clinical trials remotely, and the availability of electronic patient-reported outcomes (ePRO).
    Full story
  • Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

    Nov 2, 2023, 08:58 by
    Resolian, a global bioanalytical contract research organization (CRO) specializing in drug metabolism and pharmacokinetics for small and large molecules, has acquired Denali Medpharma, a leading China-based bioanalytical CRO
    Full story
  • Amerigo Scientific Rolls Out Real-Time PCR Kits to Facilitate HAV Research

    Nov 2, 2023, 08:58 by
    Full story
  • CD BioSciences Releases Biophysical Analysis Services to Speed Up Drug Discovery and Biomedical Research

    Nov 2, 2023, 08:58 by
    Full story
  • Creative Diagnostics Launches Carbamazepine Test Reagents

    Nov 1, 2023, 09:15 by
    Creative Diagnostics has announced the release of its new line of Carbamazepine Test Reagents.
    Full story
  • STEMart Launches Disinfection Efficacy Studies Services for Medical Devices

    Nov 1, 2023, 09:15 by
    STEMart has announced the launch of its Disinfection Efficacy Studies Services in various standards to ensure the safety of medical devices.
    Full story
  • CD Bioparticles Announces the Launch of New Flow Cytometry Particles

    Nov 1, 2023, 09:15 by
    CD Bioparticles has announced a range of new Flow Cytometry Particles.
    Full story
  • New ‘One World, One Health’ Report Shows Critical Need for Closer Collaboration Between Key Stakeholders Across Human, Animal, and Environmental Health

    Nov 1, 2023, 09:15 by
    Full story
  • Evaluating Risk in the Era of Decentralized Clinical Trials

    Nov 1, 2023, 01:00 by User Not Found
    Clinical Research News | Since the pandemic, decentralized trials have claimed the lion’s share of conversation around trial design and participant engagement. When it comes to risk-based quality management, decentralized trials can also mean decentralized control. More options for patients means more opportunity for risk.
    Full story
  • Sexy Science, Clinical Ops as a Business, Data Custodians

    Oct 31, 2023, 01:00 by User Not Found
    Clinical Research News | Bravard’s opening keynote at SCOPE Europe challenged the community to view clinical ops as a growth driver for business and inspired them to fight the good fight.
    Full story
  • Revolutionizing Metabolomics: Creative Proteomics Unveils LC-MS/MS Untargeted Metabolomics Service

    Oct 30, 2023, 08:54 by
    Full story
  • Innovative SILAC-Based Proteomics Analysis Service Launched by Creative Proteomics

    Oct 30, 2023, 08:54 by
    Full story
  • «
  • 61
  • 62
  • 63
  • 64
  • 65 (current)
  • 66
  • 67
  • 68
  • 69
  • 70
  • »